Cutler Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Cutler Group’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-100	Closed	–	–	5323
2018 Q1	$0	Buy	+100	New	+$149	﹤0.01%	5770
2017 Q3	–	Sell	-536	Closed	–	–	7257
2017 Q2	$0	Sell	536 -1	-0.2%	-$2	﹤0.01%	7576
2017 Q1	$1K	Sell	537 -175	-25%	-$827	﹤0.01%	6194
2016 Q4	$3K	Buy	712 +387	+119%	+$6.7K	﹤0.01%	5482
2016 Q3	$8K	Sell	325 -662	-67%	-$16.7K	﹤0.01%	4526
2016 Q2	$24K	Buy	987 +538	+120%	+$15.2K	﹤0.01%	3184
2016 Q1	$13K	Sell	449 -525	-54%	-$14.2K	﹤0.01%	3801
2015 Q4	$36K	Buy	+974	New	+$43K	﹤0.01%	2822

Other funds holding ANTH

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Cutler Group's ANTH Position: Q2 2018 in Review

Cutler Group sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 100 shares.

Cutler Group first reported a position in ANTH in Q4 2015 and held it in 8 quarters. The position peaked at $36K in Q4 2015. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.

Cutler Group reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Cutler Group sold 100 Anthera Pharmaceuticals, Inc. shares in Q2 2018.
Cutler Group first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2015 and held it in 8 quarters.
Cutler Group's Anthera Pharmaceuticals, Inc. position peaked at $36K in Q4 2015.
5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.

Based on Cutler Group's 13F filing for Q2 2018, filed 10 Aug 2018.